Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 372

1.

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS.

J Clin Oncol. 2014 Sep 20;32(27):2959-67.

PMID:
25513417
[PubMed - in process]
2.

Yeast HXK2 gene reverts glucose regulation mutation of penicillin biosynthesis in P. chrysogenum.

Pérez EA, Fernández FJ, Fierro F, Mejía A, Marcos AT, Martín JF, Barrios-González J.

Braz J Microbiol. 2014 Oct 9;45(3):873-83. eCollection 2014.

PMID:
25477921
[PubMed - in process]
Free PMC Article
3.

Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831.

Perez EA, Romond EH, Suman VJ, Jeong JH, Sledge G, Geyer CE Jr, Martino S, Rastogi P, Gralow J, Swain SM, Winer EP, Colon-Otero G, Davidson NE, Mamounas E, Zujewski JA, Wolmark N.

J Clin Oncol. 2014 Nov 20;32(33):3744-52. doi: 10.1200/JCO.2014.55.5730. Epub 2014 Oct 20.

PMID:
25332249
[PubMed - in process]
4.

Highlights in breast cancer from the 2014 American Society of Clinical Oncology® annual meeting.

Perez EA.

Clin Adv Hematol Oncol. 2014 Jul;12(7):451-3. No abstract available.

PMID:
25322325
[PubMed - in process]
5.

Laparoscopic Ladd's procedure for superior mesenteric artery syndrome.

Alsulaimy M, Tashiro J, Perez EA, Sola JE.

J Pediatr Surg. 2014 Oct;49(10):1533-5. doi: 10.1016/j.jpedsurg.2014.07.008. Epub 2014 Aug 13.

PMID:
25280662
[PubMed - in process]
6.

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Schink JC, Trosman JR, Weldon CB, Siziopikou KP, Tsongalis GJ, Rademaker AW, Patel JD, Benson AB 3rd, Perez EA, Gradishar WJ.

J Natl Cancer Inst. 2014 Sep 12;106(10). pii: dju256. doi: 10.1093/jnci/dju256. Print 2014 Oct.

PMID:
25217578
[PubMed - indexed for MEDLINE]
7.

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S.

Ann Oncol. 2014 Sep 11. pii: mdu450. [Epub ahead of print] Review.

PMID:
25214542
[PubMed - as supplied by publisher]
8.

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole.

Ingle JN, Kalari KR, Buzdar AU, Robson ME, Goetz MP, Desta Z, Barman P, Dudenkov TT, Northfelt DW, Perez EA, Flockhart DA, Williard CV, Wang L, Weinshilboum RM.

Steroids. 2014 Aug 24. pii: S0039-128X(14)00200-1. doi: 10.1016/j.steroids.2014.08.007. [Epub ahead of print]

PMID:
25163006
[PubMed - as supplied by publisher]
9.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.

de Azambuja E, Holmes AP, Piccart-Gebhart M, Holmes E, Di Cosimo S, Swaby RF, Untch M, Jackisch C, Lang I, Smith I, Boyle F, Xu B, Barrios CH, Perez EA, Azim HA Jr, Kim SB, Kuemmel S, Huang CS, Vuylsteke P, Hsieh RK, Gorbunova V, Eniu A, Dreosti L, Tavartkiladze N, Gelber RD, Eidtmann H, Baselga J.

Lancet Oncol. 2014 Sep;15(10):1137-46. doi: 10.1016/S1470-2045(14)70320-1. Epub 2014 Aug 14.

PMID:
25130998
[PubMed - in process]
10.

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.

Schneider BP, Li L, Shen F, Miller KD, Radovich M, O'Neill A, Gray RJ, Lane D, Flockhart DA, Jiang G, Wang Z, Lai D, Koller D, Pratt JH, Dang CT, Northfelt D, Perez EA, Shenkier T, Cobleigh M, Smith ML, Railey E, Partridge A, Gralow J, Sparano J, Davidson NE, Foroud T, Sledge GW.

Br J Cancer. 2014 Sep 9;111(6):1241-8. doi: 10.1038/bjc.2014.430. Epub 2014 Aug 12.

PMID:
25117820
[PubMed - indexed for MEDLINE]
11.

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial.

Cheng H, Ballman K, Vassilakopoulou M, Dueck AC, Reinholz MM, Tenner K, Gralow J, Hudis C, Davidson NE, Fountzilas G, McCullough AE, Chen B, Psyrri A, Rimm DL, Perez EA.

Br J Cancer. 2014 Sep 9;111(6):1065-71. doi: 10.1038/bjc.2014.442. Epub 2014 Aug 12.

PMID:
25117817
[PubMed - indexed for MEDLINE]
12.

Infant with bilateral pulmonary sequestrations with portal venous drainage excised by video-assisted thoracic surgery.

Parikh PP, Tashiro J, Chahwala V, Perez EA, Sola JE.

J Pediatr Surg. 2014 Aug;49(8):1332-4. doi: 10.1016/j.jpedsurg.2014.06.004. Epub 2014 Jul 10.

PMID:
25092101
[PubMed - in process]
13.

Trauma induced hypercoagulablity in pediatric patients.

Ryan ML, Van Haren RM, Thorson CM, Andrews DM, Perez EA, Neville HL, Sola JE, Proctor KG.

J Pediatr Surg. 2014 Aug;49(8):1295-9. doi: 10.1016/j.jpedsurg.2013.11.050. Epub 2013 Nov 16.

PMID:
25092093
[PubMed - in process]
14.

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS.

J Clin Oncol. 2014 Sep 20;32(27):2959-66.

PMID:
25071121
[PubMed - in process]
15.

Association studies of Fcγ receptor polymorphisms with outcome in HER2+ breast cancer patients treated with trastuzumab in NCCTG (Alliance) Trial N9831.

Norton N, Olson RM, Pegram M, Tenner K, Ballman KV, Clynes R, Knutson KL, Perez EA.

Cancer Immunol Res. 2014 Oct;2(10):962-9. doi: 10.1158/2326-6066.CIR-14-0059. Epub 2014 Jul 2.

PMID:
24989892
[PubMed - in process]
16.

Immunoscoring breast cancer: TILs remember what they target.

Curigliano G, Perez EA.

Ann Oncol. 2014 Aug;25(8):1455-6. doi: 10.1093/annonc/mdu227. Epub 2014 Jun 20. No abstract available.

PMID:
24950980
[PubMed - in process]
17.

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Shulman LN, Berry DA, Cirrincione CT, Becker HP, Perez EA, O'Regan R, Martino S, Shapiro CL, Schneider CJ, Kimmick G, Burstein HJ, Norton L, Muss H, Hudis CA, Winer EP.

J Clin Oncol. 2014 Aug 1;32(22):2311-7. doi: 10.1200/JCO.2013.53.7142. Epub 2014 Jun 16.

PMID:
24934787
[PubMed - indexed for MEDLINE]
18.

New developments in metastatic breast cancer: integrating recent data into clinical practice.

Perez EA, Rugo HS, Vahdat LT.

Clin Adv Hematol Oncol. 2013;11(10 Suppl 16):1-18; quiz 19.

PMID:
24892840
[PubMed - indexed for MEDLINE]
19.
20.

A nationwide analysis of clinical outcomes among newborns with esophageal atresia and tracheoesophageal fistulas in the United States.

Wang B, Tashiro J, Allan BJ, Sola JE, Parikh PP, Hogan AR, Neville HL, Perez EA.

J Surg Res. 2014 Aug;190(2):604-12. doi: 10.1016/j.jss.2014.04.033. Epub 2014 Apr 28.

PMID:
24881472
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk